moyamoya disease การใช้

• The arterial constrictions in moyamoya disease are unlike the constrictions in atherosclerosis.
• Moyamoya disease can be either congenital or acquired.
• Moyamoya disease tends to affect adults in the third to fourth decade of life.
• Recently, Moyamoya disease has also been identified as a potential cause for brain ischemia.
• No signs of Moyamoya disease was discovered, however she regularly sees a doctor to monitor her condition.
• Conventional angiography provided the conclusive diagnosis of moyamoya disease in most cases and should be performed before any surgical considerations.
• The pathogenesis of moyamoya disease is unknown, although the gene ring finger protein 213 ( RNF213 ) has been implicated.
• Moyamoya disease is an extremely rare cerebrovascular condition that limits blood circulation to the brain, consequently leading to oxygen deprivation.
• At one point Matsushima was examined for Moyamoya disease like symptoms, including disturbance of blood flow to the brain, headaches and fainting.
• Often nuclear medicine studies such as SPECT ( single photon emission computerized tomography ) are used to demonstrate the decreased blood and oxygen supply to areas of the brain involved with moyamoya disease.
• It has been related to Moyamoya disease and it seems likely that certain mutations in heterozygosis could confer a predisposition to many vascular pathologies, such as thoracic aortic aneurysm and ischaemic heart disease.
• There are reports of ETS being used to achieve cerebral revascularization for people with moyamoya disease, and to treat headaches, hyperactive bronchial tubes, long QT syndrome, social phobia, anxiety, and other conditions.
• Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ, Kim DH, Pannu H, Willing MC, Sparks E, Pyeritz RE, Singh MN, Dalman RL, Grotta JC, Marian AJ, Boerwinkle EA, Frazier LQ, LeMaire SA, Coselli JS, Estrere AL, Safi HJ, Veeraraghavan S, Munzy DM, Wheeler, DA, Willerson JT . Mutations in smooth muscle alpha-actin ( ACTA2 ) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease.